SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals trades jubilantly on the bourses

23 Aug 2017 Evaluate

SMS Pharmaceuticals is currently trading at Rs. 84.65, up by 11.65 points or 15.96% from its previous closing of Rs. 73.00 on the BSE.

The scrip opened at Rs. 74.00 and has touched a high and low of Rs. 87.60 and Rs. 73.95 respectively. So far 181934 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 115.00 on 06-Oct-2016 and a 52 week low of Rs. 66.60 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 87.60 and Rs. 70.25 respectively. The current market cap of the company is Rs. 676.37 crore.

The promoters holding in the company stood at 67.99% while Institutions and Non-Institutions held 0.18% and 31.83% respectively.

SMS Pharmaceuticals’ manufacturing facility-Unit II located at Bachupally, Ranga Reddy District, Hyderabad, Telangana, India was successfully inspected by Pharmaceuticals and Medical Devices Agency (PMDA), Japan Authorities. The inspection was carried out between July 25, 2017 to July 27, 2017.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.


PMDA inspects SMS Pharmaceuticals’ manufacturing facility at Telangana



SMS Pharmaceuticals Share Price

427.60 3.45 (0.81%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×